Turbuhaler is an inspiratory flow-driven, multidose dry-powder inhaler that is easy to use and has an extensive clinical documentation in respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD).
Turbuhaler offers high lung deposition of various inhaled drugs, with minimal delivery to unwanted areas, e.g. the mouth and pharynx. It features a multidose system that is preloaded, easily handled, and does not require coordination between actuation and inhalation.
Turbuhaler was designed specifically to eliminate the need for propellants (e.g. CFCs). The unique design of Turbuhaler has been commended by several awards, including Stratospheric Ozone Protection Award from the US Environmental Protection Agency in 1991.
AstraZeneca offers a number of products that use the Turbuhaler device, including Symbicort Turbuhaler, Pulmicort Turbuhaler, Oxis Turbuhaler, Bricanyl Turbuhaler and Rhinocort Turbuhaler.
The trade name Turbohaler is used in some countries.